Search alternatives:
teer decrease » greater decrease (Expand Search)
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » greater decrease (Expand Search)
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
321
-
322
-
323
-
324
-
325
Retinoic acid alleviates decreases of phospho-Akt and phospho-Bad expression caused by MCAO damage.
Published 2024“…Molecular weight (kDa) are depicted at right. Data (<i>n</i> = 5) are represented as mean ± S.E.M. *<i>p</i> < 0.001, **<i>p</i> < 0.01 vs. vehicle + sham animals, #<i>p</i> < 0.01 vs. vehicle + MCAO animals.…”
-
326
-
327
-
328
-
329
Fig 5 -
Published 2022“…All recordings are available from (S2 Fig in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0266769#pone.0266769.s001" target="_blank">S1 File</a>) <b>(B)</b> Critical speed measurement in Ansys workbench <b>B.i)</b> Meshing of Design C (Nodes: 6749, Elements: 39228) C <b>B.ii)</b> Mode shape during natural frequency <b>B.iii)</b> Simulated (model) vs experimental critical speed of each conical shape design showing a good agreement between them with low percentage difference (1–5%) <b>(C)</b> Measured deflection of each conical shape design showing all designs experiencing deflection from 4 to 7 mm <b>(D)</b> Duration of deflection higher than 1.5 mm was decreasing the lowering of critical speed except design E5 which experienced higher deflection for longer times.…”
-
330
-
331
-
332
-
333
-
334
-
335
-
336
-
337
Example of a natural disaster occurring at the elevator’s county of operation.
Published 2025Subjects: -
338
-
339
-
340
Drp1<sup>SD</sup> overexpression in Opa1 or Marf depleted type II NBs rescues the reduced mitochondrial membrane potential.
Published 2022“…<p>A, B: Representative images showing decreased TMRM intensity in <i>opa1</i> RNAi and <i>marf</i> RNAi expressing type II NBs. …”